Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-21

Clinical Trial Update: Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravenous dexketoprofen in combination with paracetamol for headaches caused by acute migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexketoprofen (dexketoprofen)
  • Paracetamol (acetaminophen)

Snippet

Sponsor: Pamukkale University | Conditions: Acute Migraine | Phase 4 | Status: COMPLETED